Fundrise's co-founder and CEO, Ben Miller, says the new tool goes far beyond what more generalized AI, like ChatGPT, can offer.

Now that artificial intelligence platforms are proven and refined, the world needs a way of making it readily accessible to ...

Jan 27 (Reuters) - Intellia Therapeutics said on ‌Tuesday ​that the U.S. drug ‌regulator has lifted a clinical hold on ​one of its late-stage gene therapy trials, allowing the company to resume ...